Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Sipai Health Technology Co's share price is €0.139.
Sipai Health Technology Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €0.42. Hence, Sipai Health Technology Co's PS Ratio for today is 0.33.
The historical rank and industry rank for Sipai Health Technology Co's PS Ratio or its related term are showing as below:
FRA:AX1'
s PS Ratio Range Over the Past 10 Years
Min: 0.13 Med: 0.63 Max: 4.48
Current: 0.4
During the past 7 years, Sipai Health Technology Co's highest PS Ratio was 4.48. The lowest was 0.13. And the median was 0.63.
FRA:AX1's PS Ratio is ranked better than 52.54% of 118
companies
in the Medical Distribution industry
Industry Median: 0.415
vs FRA:AX1: 0.40
During the past 7 years, Sipai Health Technology Co's highest 3-Year average Revenue per Share Growth Rate was 200.00% per year. The lowest was -54.70% per year. And the median was 17.50% per year.
Sipai Health Technology Co (FRA:AX1) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Sipai Health Technology Co PS Ratio Related Terms
Sipai Health Technology Co PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Sipai Health Technology Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sipai Health Technology Co PS Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sipai Health Technology Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Sipai Health Technology Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Sipai Health Technology Co's Share Price of today is €0.139.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sipai Health Technology Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €0.42.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Sipai Health Technology Co (FRA:AX1) has a PS Ratio of 0.33 as of Aug. 20, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Sipai Health Technology Co and its competitors. This is 48% below median its historical median of 0.63. Over the past decade, Sipai Health Technology Co's PS Ratio has ranged from 0.13 to 4.48. According to the industry distribution chart, Sipai Health Technology Co ranks #56 out of 118 companies in the Medical Distribution industry, placing it in the top 47.5%.
Is Sipai Health Technology Co's PS Ratio too high?
Sipai Health Technology Co's current PS Ratio of 0.33 is 48% below median its 10-year median of 0.63. Over the past 10 years, this metric has ranged from a low of 0.13 to a high of 4.48. The Medical Distribution industry median PS Ratio is 0.42. Sipai Health Technology Co's value of 0.33 is 20.5% below this industry median. Based on the distribution chart, Sipai Health Technology Co ranks #56 out of 118 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Sipai Health Technology Co has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does Sipai Health Technology Co's PS Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Sipai Health Technology Co ranks #56 out of 118 companies for PS Ratio. This puts Sipai Health Technology Co in the upper half of its industry. The industry median PS Ratio is 0.42. Sipai Health Technology Co's value of 0.33 is 20.5% below this benchmark. Historically, Sipai Health Technology Co's own PS Ratio has ranged from 0.13 to 4.48 over the past decade. While the company's 10-year median is 0.63 vs. the industry median of 0.42, Sipai Health Technology Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Distribution company?
The median PS Ratio among Medical Distribution companies is 0.42, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sipai Health Technology Co's current PS Ratio of 0.33 is 20.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Sipai Health Technology Co and its competitors. For the Medical Distribution industry, the median PS Ratio is 0.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sipai Health Technology Co's current PS Ratio is 0.33, which is 48% below median its own 10-year median of 0.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sipai Health Technology Co stock overvalued right now?
Sipai Health Technology Co (FRA:AX1) has a current PS Ratio of 0.33. The stock's GF Value™ is €0.22, compared to a current price of €0.14 — trading 36.8% below its estimated fair value. The current PS Ratio is 0.33, which is 48% below median its 10-year median of 0.63 and 20.5% below the Medical Distribution industry median of 0.42. Sipai Health Technology Co's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Sipai Health Technology Co (FRA:AX1), the current PS Ratio is 0.33 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sipai Health Technology Co (FRA:AX1) Overvalued in 2026?
Based on GuruFocus' analysis, Sipai Health Technology Co stock appears to be undervalued.
The current stock price of €0.14 is trading 36.8% below its estimated GF Value™ of €0.22.
Key valuation signals for FRA:AX1:
PS Ratio: 0.33 (48% below median its 10-year median of 0.63)
GF Value™: €0.22 vs. price of €0.14 (36.8% below fair value)
Industry Position: 20.5% below the Medical Distribution median (#56 of 118)
No single metric tells the full story. See the FRA:AX1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sipai Health Technology Co Ltd is a medical technology and health management company in China. The company has three reportable operating segments: Specialty Pharmacy Business - engaged in the operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Commercial Insurance Services Business - rendering insurance brokerage services to insurance companies and health management services to insurance carriers and enterprise clients. The company generates key revenue from the Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.
64GF Score
Get the complete analysis for FRA:AX1
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:AX1 has been successfully added to your 
